The global heparin market value in 2022 was USD 8.70 billion, driven by the ongoing research and development in heparin-based therapies the globe. The market size is anticipated to grow at a CAGR of 4.4% during the forecast period of 2023-2031 to achieve a value of USD 12.80 billion by 2031.
North America is the largest market for heparin, driven by factors such as the high prevalence of chronic diseases, advanced healthcare infrastructure, and a strong focus on research and development.
Europe is the second-largest market, with increasing demand for heparin due to a growing awareness of its therapeutic benefits and a supportive regulatory framework.
Asia Pacific is expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.
Heparin: Introduction
Heparin is a naturally occurring anticoagulant, widely used in medical practice to prevent and treat blood clots in various clinical settings. It is derived from animal tissues, primarily porcine intestinal mucosa or bovine lung. Heparin plays a vital role in managing a range of conditions, including deep vein thrombosis (DVT), pulmonary embolism, and during surgical procedures such as coronary artery bypass grafting and dialysis. The heparin market is segmented into two main types: unfractionated heparin (UFH) and low molecular weight heparin (LMWH).Heparin Market Scenario
The global market for heparin has experienced substantial growth over recent years, driven by factors such as the increasing prevalence of chronic diseases, an aging population, and the growing demand for anticoagulant therapies. The market has also been influenced by ongoing research and development in heparin-based therapies, advancements in manufacturing processes, and supportive regulatory policies.North America is the largest market for heparin, driven by factors such as the high prevalence of chronic diseases, advanced healthcare infrastructure, and a strong focus on research and development.
Europe is the second-largest market, with increasing demand for heparin due to a growing awareness of its therapeutic benefits and a supportive regulatory framework.
Asia Pacific is expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing investments in healthcare infrastructure.
Heparin Market Segmentations
Market Breakup by Type
Low Molecular Weight Heparin
- Intravenous
- Subcutaneous
Ultra-Low Molecular Weight Heparin
- Intravenous
- Subcutaneous
Unfractionated Heparin
- Intravenous
- Subcutaneous
Market Breakup by Application
- Venous Thromboembolism
- Atrial Fibrillation
- Renal Impairment
- Coronary Artery Disease
- Others
Market Breakup by Mode of Administration
- Intravenous
- Subcutaneous
Market Breakup by End User
- Outpatient
- Inpatient
Market Breakup by Source
- Porcine
- Bovine
- Others
Market Breakup by Region
North America
- United States of America
- Canada
Europe
- United Kingdom
- Germany
- France
- Italy
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Trends in the Heparin Market
Some key trends of the market are as follows:- Rising demand for low molecular weight heparin (LMWH): LMWH has gained popularity due to its higher bioavailability, more predictable anticoagulant response, and a lower risk of adverse effects compared to UFH. This has resulted in an increasing demand for LMWH in various therapeutic applications
- Technological advancements in heparin production: Ongoing research and development efforts have led to the discovery of novel heparin production methods and improved purification techniques, contributing to market growth
- Expansion of therapeutic applications: The development of heparin-based therapies for new indications, such as cancer treatment and wound healing, has further fuelled the market growth
Heparin Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- GlaxoSmithKline plc
- Pfizer Inc
- Leo Pharma A/S
- Sanofi S.A
- Dr. Reddy’s Laboratories Ltd
- Aspen Pharmacare Holdings Limited
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Sandoz (Novartis AG)
- Teva Pharmaceuticals
- Viatris Inc.
Table of Contents
1 Preface
3 Global Heparin Market Overview
4 Global Heparin Market Landscape
5 Global Heparin Market Dynamics
6 Global Heparin Market Segmentation
7 North America Heparin Market
8 Europe Heparin Market
9 Asia Pacific Heparin Market
10 Latin America Heparin Market
11 Middle East and Africa Heparin Market
12 Patent Analysis
13 Grants Analysis
14 Funding Analysis
15 Partnership and Collaborations Analysis
16 Regulatory Framework
17 Supplier Landscape
18 Global Heparin Market- Distribution Model (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
21 Payment Methods (Additional Insight)
Companies Mentioned
- GlaxoSmithKline plc
- Pfizer Inc.
- Leo Pharma A/S
- Sanofi S.A
- Dr. Reddy’S Laboratories Ltd.
- Aspen Pharmacare Holdings Limited
- B. Braun Melsungen AG
- Fresenius Kabi AG
- Sandoz (Novartis Ag)
- Teva Pharmaceuticals
- Viatris Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 147 |
| Published | May 2023 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 9.1 Billion |
| Forecasted Market Value ( USD | $ 12.8 Billion |
| Compound Annual Growth Rate | 4.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
